NL-201 Upregulates MHC-I Expression and Intratumoral T-cell Receptor Diversity, and Demonstrates Robust Antitumor Activity as Monotherapy and in Combination with PD-1 Blockade
NL-201 上调 MHC-I 表达和肿瘤内 T 细胞受体多样性，并作为单一疗法和与 PD-1 阻断剂联合使用表现出强大的抗肿瘤活性
期刊:Cancer Immunology Research
影响因子:8.1
doi:10.1158/2326-6066.CIR-22-0304
Christie Mortales, Benjamin Dutzar, Jerry Chen, Alex Chen, Justin Huard, Carl Walkey, Ryan Swanson
